- Healthcare Professionals
- Research
- Clinical trials
- Elevate study
Elevate Study
A multicentre, open-label, randomised, phase IV study to investigate acalabrutinib monotherapy compared to investigator’s choice of treatment in adults (> 18 years) with chronic lymphocytic leukaemia and moderate to severe cardiac impairment.
Trial overview
Disease
Haematology
Topic
Diagnostics
Sponsor
Astra Zeneca
Description
A multicentre, open-label, randomised, phase IV study to investigate acalabrutinib monotherapy compared to investigator’s choice of treatment in adults (> 18 years) with chronic lymphocytic leukaemia and moderate to severe cardiac impairment.
Study details
For detailed information on this trial, please click here
Trial status
Open and recruiting June 2025
Location
Principal Investigator
Dr Toby Eyre
MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD (University of Newcastle)
Consultant Haematologist
Oxford
